Can a powder drink beat the hangover? new trial tests alcovit
NCT ID NCT07332429
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests whether Alcovit, a powder containing zeolite clinoptilolite and vitamins, can reduce blood alcohol levels and hangover severity in healthy adults. About 228 occasional or moderate drinkers will take Alcovit or a placebo either just before or right after drinking a standard amount of alcohol. Researchers will measure blood alcohol, breathalyzer readings, and hangover symptoms over 60 minutes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Alcovit (zeolite clinoptilolite with B vitamins, vitamin C, and chlorophyllin)
What this could lead to
If it works, this could point toward a way to reduce blood alcohol levels and hangover severity after drinking.
What could go wrong
This is an early trial with no phase assigned, so results are uncertain. The effect may be small or no better than placebo, and it does not prevent intoxication or alcohol-related harm.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL DRINKING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Santa Casa de Misericórdia de Campos
Campos dos Goytacazes, Rio de Janeiro, 28035-053, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••